Embecta Corp. is on the Cruelty-Free Investing usage of animals list because their parent company Becton, Dickinson undertakes pre-clinical studies on animals to examine the safety profile of their medications.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing patient’s diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Company Website: https://www.embecta.com